Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope.
Rawan TahaOla KaderSherine ShawkyShahinda RezkPublished in: Annals of clinical microbiology and antimicrobials (2023)
This synergistic effect spots the light on new therapeutics for XDR and PDR CPE.